,i #aafth ,,congress #ast ,session ,h4 ,r4 #caga ,,in ,,the ,,house ,,of ,,representatives ,june #aj1 #bjai,ms4 ,bonamici 7for herself1 ,ms4 ,kuster of ,new ,hampshire1 ,ms4 ,wild1 ,ms4 ,johnson of ,texas1 and ,mrs4 ,dingell7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to amend the ,comprehensive ,addiction and ,recovery ,act of #bjaf to authorize the ,attorney ,general1 in coordination with the ,administrator of the ,drug ,enforcement ,administration1 the ,secretary of ,health and ,human ,services1 and the ,director of the ,office of ,national ,drug ,control ,policy1 to award grants to covered entities to establish or maintain disposal sites for unwanted prescription medications1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,safe ,disposal of ,opioids ,act of #bjai4 #b4 ,grants for disposal sites for unwanted prescription medications ,section #bjc of the ,comprehensive ,addiction and ,recovery ,act of #bjaf 7#ba ,u4,s4,c4 #hbb;a7 is amended by adding at the end the following3 7c7 ,grants for disposal sites for unwanted prescription medications 7#a7 ,grants 7,a7 ,awards ,in carrying out subsection 7b71 the ,attorney ,general shall award grants to covered entities to establish or maintain disposal sites for unwanted prescription medications4 7,b7 ,limitation ,of the total amount of awards under subparagraph 7,a7 for a fiscal year1 the ,attorney ,general shall not award more than #aj percent to covered entities that are-- 7i7 ,state1 local1 or tribal law enforcement agencies2 or 7ii7 manufacturers1 distributors1 or reverse distributors of prescription medications4 7#b7 ,discounts for eligible patients 7,a7 ,in general ,the ,secretary of ,health and ,human ,services shall establish a mechanism by which amounts paid by an eligible patient for an active opioid are discounted at time of payment or purchase to ensure that such patient does not pay any amount attributable to a fee under paragraph 7#c71 with as little burden on the patient as possible4 7,b7 ,definition ,for purposes of subparagraph 7,a71 the term eligible patient means-- 7i7 a patient for whom any active opioid 7as so defined7 is prescribed to treat pain relating to cancer or cancer treatment2 7ii7 a patient participating in hospice care2 and 7iii7 in the case of the death or incapacity of a patient described in subparagraph 7,a7 or 7,b7 or any similar situation as determined by the ,secretary of ,health and ,human ,services1 the appropriate family member1 medical proxy1 or similar representative or the estate of such patient4 7#c7 ,fees 7,a7 ,in general ,there is hereby imposed on the sale of any active opioid by the manufacturer1 producer1 or importer a fee equal to #a cent per #ajj milligrams so sold4 7,b7 ,special rules 7i7 ,definition ,in this paragraph1 the term active opioid-- 7,i7 means any controlled substance 7as defined in section #ajb of the ,controlled ,substances ,act1 as in effect on the date of the ,safe ,disposal of ,opioids ,act of #bjai7 which is opium1 an opiate1 or any derivative thereof2 and 7,,ii7 excludes any prescribed drug which is used exclusively for the treatment of opioid addiction as part of a medically assisted treatment effort4 7ii7 ,exclusion of other ingredients ,in the case of a product that includes an active opioid and another ingredient1 subparagraph 7,a7 shall apply only to the portion of such product that is an active opioid4 7#d7 ,authorization of appropriations ,for fiscal year #bjbj and each subsequent fiscal year1 there is authorized to be appropriated to carry out this subsection an amount not to exceed the aggregate amount of the fees collected pursuant to paragraph 7#c74 4